Whirlpool and Mattel CEOs discuss earnings and consumer trends. Topics include soft discretionary purchases, strong replacement business, impact of Barbie movie on sales, and strong holiday season for Mattel. Also explores the importance of trust and transparent AI systems, risks and challenges of cryptocurrency investment, and regulatory outlook for Bitcoin.

Former CEO of Panera Bread and Au Bon Pain, Ron Shaich, discusses his book 'Know What Matters: Lessons from a Lifetime of Transformations.' Topics include building dominant brands, running private vs. public companies, challenges and humanity of running a public company, and choices, trade-offs, and finding opportunities in fast casual.

Rick Wurster discusses the challenges advisors are facing. Joe Grogan talks about making investing simple. Kathy Jones explains the unprecedented year for bonds. Jalina Kerr provides details on products for Schwab's RIA clients.

Shehzad Qazi, COO at China Beige Book International, discusses the 'boring' recovery of the Chinese economy. Dr. Allan Evans talks about drone use in wars. Topics include sovereign debt, investor confidence, carbon emissions solutions, trust in tech, open source AI, and drones in military conflicts.

James Cakmak shares thoughts on Alphabet and Microsoft earnings, Marc Champion discusses a way forward in the Middle East without Hamas, Max Chafkin highlights Wikipedia's reliability, and Sam Stovall provides investment insights.

Jess Hunichen and Emily Ward, Co-Founders of Shine Ventures, discuss their transition from influencer management to angel investing. They highlight the earning potential in the content creation space, their involvement in product development, and their focus on the menstruation through menopause space. They also explore reducing carbon emissions, investing in startups, and the connection between women's health and social media engagement.

Topics include investing in China, the Chevron-Hess deal, the Israel-Hamas conflict, reducing carbon emissions, AI in creativity and trust, the declining trend of China trade, open source and AI, and opportunities in equity.

Madison Muller, Bloomberg News Health Reporter, discusses the drug Ozempic and its potential to treat various health conditions such as kidney disease, heart disease, Alzheimer's, and alcohol use disorder. The podcast explores the groundbreaking effects of GLP1 receptor agonists in treating diabetes and promoting weight loss. It also delves into the potential benefits and implications of weight loss treatments and the recent popularity of using diabetes drugs for weight loss.

Former CIA paramilitary officer Mick Mulroy and Bloomberg Opinion columnist Bobby Ghosh discuss the Israel-Hamas conflict. Tom McGee gives his forecast for holiday spending season. Joel Weber and Ari Altstedter talk about Lululemon founder Chip Wilson's quest for a cure for muscular dystrophy.

The podcast explores topics such as carbon emissions reduction, the conflict between Israel and Palestine, the rising global cost of cybercrime, concerns about digital tracking and surveillance, meta's reliance on personalized advertising, Taylor Swift's mission to rerecord her albums, and the breakthrough drug Oseptic.